Comparative efficacy and safety of Chinese patent medicines for primary insomnia: A systematic review and network meta-analysis of 109 randomized trials
Journal of Ethnopharmacology · 2025
DOI: 10.1016/j.jep.2024.119254 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Ethnopharmacology, 2025. Verfasst von Ning Ma und 20 weiteren Autor:innen. Beteiligte Einrichtung: Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, 730000, China; Centre for Evidence-Based Social Scienc…. Hauptthemen laut MEDLINE: Sleep Initiation and Maintenance Disorders, Drugs, Chinese Herbal, Nonprescription Drugs. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 148 Literaturangaben. Gefördert von: China Academy of Traditional Chinese Medicine.
Themen: Schlaf
Abstract (Originalsprache)
ETHNOPHARMACOLOGICAL RELEVANCE: Chinese patent medicine (CPM) is formulated using Chinese herbal medicines as raw materials according to prescribed methods and preparation processes. It is one of the most commonly used complementary and alternative therapies for insomnia in China. Dozens of CPMs have been applied in clinical settings to treat primary insomnia, and ample evidence has proven the efficacy and safety of various CPMs. AIM OF THE STUDY: We aimed to use the network meta-analysis method to simultaneously compare the efficacy and safety of Chinese patent medicines for primary insomnia. MATERIALS AND METHODS: We systematically searched eight databases from their inception to July 2022. The relevant randomized controlled trials (RCTs) were eligible if they compared one CPM or one CPM plus a Western drug with another CPM or with Western drug/placebo in adults with primary insomnia. Two reviewers independently performed literature screening, data extraction, and risk of bias assessment. We evaluated the certainty of evidence utilizing CINeMA (Confidence in Network Meta-Analysis) framework. RESULTS: A total of 109 RCTs involved 11,488 patients (54.26% female) with a median age of 47.97 years. Forty-five CPMs were assessed in this study. Compared with placebo and Benzodiazepine drugs, Shugan Jieyu capsules, Shenqi Wuweizi tablets, and Tianmeng oral liquid/capsules combined with Benzodiazepine drugs significantly improved sleep quality. Compared to Benzodiazepine drugs, both Shenqi Wuweizi tablets and Anshen Bunao liquid/granules significantly prolonged subjective total sleep duration and reduced sleep onset latency. Considering safety, all CPMs showed an insignificant difference or lower risk of gastrointestinal and dizziness events compared to Western drugs or placebo. The certainty of evidences was rated as low or very low. CONCLUSION: This meta-analysis demonstrated the efficacy and safety of CPMs for primary insomnia, especially several CPMs such as Shugan Jieyu capsules, Shenqi Wuweizi tablets and Tianmeng oral liquid, which have shown their potential benefits. However, the present conclusions are based on low quality trials. Well-designed trials, including rigorous methods and patient-important outcomes, are required to verify these results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, 730000, China; Centre for Evidence-Based Social Science/Center for Health Technology Assessment, School of Public Health, La…
- Institute of Basic Research of Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China; China Center for Evidence Based Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beiji…
- Centre for Evidence-Based Social Science/Center for Health Technology Assessment, School of Public Health, Lanzhou University, 730000, Lanzhou, China.
- Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, 730000, China.
- Department of Prenatal Diagnosis Center, Gansu Provincial Maternity and Child-care Hospital, Lanzhou, 730000, China.
- China Center for Evidence Based Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Förderung
- China Academy of Traditional Chinese Medicine
Zitieren
APA
Ma, N., Pan, B., Yang, S., Lai, H., Ning, J., Li, Y., Liu, J., Huang, J., Ma, Y., Hou, L., Li, D., Deng, X., Wang, X., He, X., Liu, X., Liu, Y., Jin, J., Tian, J., Ge, L., …, & Yang, K. (2025). Comparative efficacy and safety of Chinese patent medicines for primary insomnia: A systematic review and network meta-analysis of 109 randomized trials. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2024.119254
Vancouver
Ma N, Pan B, Yang S, Lai H, Ning J, Li Y, et al. Comparative efficacy and safety of Chinese patent medicines for primary insomnia: A systematic review and network meta-analysis of 109 randomized trials. Journal of Ethnopharmacology. 2025. doi:10.1016/j.jep.2024.119254
BibTeX
@article{Ma2025,
author = {Ma, Ning and Pan, Bei and Yang, Sihong and Lai, Honghao and Ning, Jinling and Li, Ying and Liu, Jianing and Huang, Jiajie and Ma, Yan and Hou, Liangying and Li, Dan and Deng, Xiyuan and Wang, Xiaoman and He, Xin and Liu, Xiaowei and Liu, Yajie and Jin, Jiayue and Tian, Jinhui and Ge, Long and Zhao, Hui and Yang, Kehu},
title = {Comparative efficacy and safety of Chinese patent medicines for primary insomnia: A systematic review and network meta-analysis of 109 randomized trials},
journal = {Journal of Ethnopharmacology},
year = {2025},
doi = {10.1016/j.jep.2024.119254}
}
EUVIMED